Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jerry Olson who wrote (74830)	12/9/1999 5:35:00 PM
From: Michael Young	Read Replies (2) of 120523

<<i'm buying CLPA, Cell Pathways....cancer drug could get approval this month at the Fda...INCREDIBLE CHART, formed a full triangle, and if it prints 12/13 it will break to the upside...resolving itself to potential large numbers...>> I'm afraid you have your facts wrong. A competitive drug will appear before the FDA oncology panel in December. CLPA's drug was NOT selected for presentation. It appears likely they won't receive a panel review until March, but that is still unclear. MIKE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next